Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren–Larsson syndrome
Authors:
- 9 March 2006
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 13 (13) , 1021-1026
Abstract
Sjögren–Larsson syndrome (SLS) is an autosomal recessive neurocutaneous disorder caused by mutation in the ALDH3A2 gene that codes for human fatty aldehyde dehydrogenase (FALDH). Sjögren–Larsson syndrome patients lack FALDH, which catalyzes the oxidation of long-chain aliphatic aldehydes to fatty acids. The impaired FALDH activity leads to congenital ichthyosis, mental retardation and spasticity. The current lack of treatment is an impetus to develop gene therapy strategies by introducing functional FALDH into defective cells. We delivered human FALDH into keratinocytes of SLS patients using recombinant adeno-associated virus-2 vectors. Transduction of SLS keratinocytes resulted in an augmentation of FALDH activity comparable to phenotypically normal heterozygous carriers. Toxicity of long-chain aldehydes for FALDH-deficient cells decreased almost to the level of unaffected keratinocytes. Three-dimensional culture of corrected SLS keratinocytes revealed an ameliorated FALDH expression. These studies demonstrate the restoration of FALDH in human SLS cells supporting the concept of gene therapy as a potential future treatment option for SLS.Keywords
This publication has 28 references indexed in Scilit:
- Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjögren-Larsson syndromeArchives of Dermatological Research, 2005
- Administration of a Replication-Deficient Adeno-Associated Virus Gene Transfer Vector Expressing the Human CLN2 cDNA to the Brain of Children with Late Infantile Neuronal Ceroid LipofuscinosisHuman Gene Therapy, 2004
- Sjögren-Larsson syndrome: Seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2Human Mutation, 2004
- Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren–Larsson syndromeChemico-Biological Interactions, 2001
- The Molecular Basis of Sjögren-Larsson Syndrome: Mutation Analysis of the Fatty Aldehyde Dehydrogenase GeneThe American Journal of Human Genetics, 1999
- Efficient gene transfer into human keratinocytes with recombinant adeno-associated virus vectorsGene Therapy, 1999
- Sjögren–Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase geneNature Genetics, 1996
- The Sjögren-Larsson Syndrome gene is close to D17S805 as determined by linkage analysis and allelic associationNature Genetics, 1994
- Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.Journal of Clinical Investigation, 1991
- Carrier detection for Sjögren‐Larsson syndromeJournal of Inherited Metabolic Disease, 1991